StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx r&d expenses

Research and development expenses are spending on new products and technology.

BioCorRx's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.37M, up 99.3% year over year. For fiscal 2025 it was $1.77M, up 19.3% from the year before. The highest annual figure on record is $4.27M in fiscal 2020.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.77M+19.3%
FY2024Dec 31, 2024$1.48M+66.4%
FY2023Dec 31, 2023$891.06K-38.9%
FY2022Dec 31, 2022$1.46M-9.1%
FY2021Dec 31, 2021$1.61M-62.4%
FY2020Dec 31, 2020$4.27M+279.9%
FY2019Dec 31, 2019$1.13M+641.3%
FY2018Dec 31, 2018$151.77K-66.3%
FY2017Dec 31, 2017$450.72K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$712.38K+140.0%
Q1 FY2026Mar 31, 2026$352.33K+117.6%
Q4 FY2025Dec 31, 2025$305.52K+12.1%
Q3 FY2025Sep 30, 2025$1.00M+118.3%
Q2 FY2025Jun 30, 2025$296.86K-44.7%
Q1 FY2025Mar 31, 2025$161.92K-24.3%
Q4 FY2024Dec 31, 2024$272.54K+112.4%
Q3 FY2024Sep 30, 2024$460.14K+60.3%
Q2 FY2024Jun 30, 2024$536.36K+125.0%
Q1 FY2024Mar 31, 2024$213.83K-9.9%
Q4 FY2023Dec 31, 2023$128.30K-35.2%
Q3 FY2023Sep 30, 2023$286.96K-59.8%
Q2 FY2023Jun 30, 2023$238.42K-63.8%
Q1 FY2023Mar 31, 2023$237.39K-74.4%
Q1 FY2022Mar 31, 2022$197.85K-84.7%
Q2 FY2021Sep 30, 2021$713.25K-47.0%
Q1 FY2021Mar 31, 2021$658.24K-7.4%
Q4 FY2020Dec 31, 2020$928.85K+70.2%
Q3 FY2020Sep 30, 2020$1.29M+332.3%
Q2 FY2020Jun 30, 2020$1.35M+895.3%
Q1 FY2020Mar 31, 2020$710.57K+386.8%
Q4 FY2019Dec 31, 2019$545.73K+857.4%
Q3 FY2019Sep 30, 2019$298.26K+734.1%
Q2 FY2019Jun 30, 2019$135.14K–
Q1 FY2019Mar 31, 2019$145.97K+147.4%
Q4 FY2018Dec 31, 2018$57.00K-80.5%
Q3 FY2018Sep 30, 2018$35.76K-66.7%
Q2 FY2018Jun 30, 2018$0-100.0%
Q1 FY2018Mar 31, 2018$59.01K+616.9%
Q4 FY2017Dec 31, 2017$291.69K–
Q3 FY2017Sep 30, 2017$107.46K–
Q2 FY2017Jun 30, 2017$43.34K–
Q1 FY2017Mar 31, 2017$8.23K–
Q2 FY2016Jun 30, 2016$0–

More BioCorRx figures

See a number that looks wrong?